Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2010 1
2011 1
2012 1
2013 1
2015 1
2016 2
2017 2
2019 3
2022 1
2023 3
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

14 results

Results by year

Filters applied: . Clear all
Page 1
Tumor-derived Autoantibodies Identify Malignant Pulmonary Nodules.
Lastwika KJ, Kargl J, Zhang Y, Zhu X, Lo E, Shelley D, Ladd JJ, Wu W, Kinahan P, Pipavath SNJ, Randolph TW, Shipley M, Lampe PD, Houghton AM. Lastwika KJ, et al. Am J Respir Crit Care Med. 2019 May 15;199(10):1257-1266. doi: 10.1164/rccm.201804-0628OC. Am J Respir Crit Care Med. 2019. PMID: 30422669 Free PMC article.
Posttranslational modifications induce autoantibodies with risk prediction capability in patients with small cell lung cancer.
Lastwika KJ, Kunihiro A, Solan JL, Zhang Y, Taverne LR, Shelley D, Rho JH, Randolph TW, Li CI, Grogan EL, Massion PP, Fitzpatrick AL, MacPherson D, Houghton AM, Lampe PD. Lastwika KJ, et al. Sci Transl Med. 2023 Jan 11;15(678):eadd8469. doi: 10.1126/scitranslmed.add8469. Epub 2023 Jan 11. Sci Transl Med. 2023. PMID: 36630482 Free PMC article.
Resistance mechanisms to genetic suppression of mutant NRAS in melanoma.
Robinson JP, Rebecca VW, Kircher DA, Silvis MR, Smalley I, Gibney GT, Lastwika KJ, Chen G, Davies MA, Grossman D, Smalley KSM, Holmen SL, VanBrocklin MW. Robinson JP, et al. Among authors: lastwika kj. Melanoma Res. 2017 Dec;27(6):545-557. doi: 10.1097/CMR.0000000000000403. Melanoma Res. 2017. PMID: 29076949 Free PMC article.
CD133 as a Biomarker for an Autoantibody-to-ImmunoPET Paradigm for the Early Detection of Small Cell Lung Cancer.
Kunihiro AG, Sarrett SM, Lastwika KJ, Solan JL, Pisarenko T, Keinänen O, Rodriguez C, Taverne LR, Fitzpatrick AL, Li CI, Houghton AM, Zeglis BM, Lampe PD. Kunihiro AG, et al. Among authors: lastwika kj. J Nucl Med. 2022 Nov;63(11):1701-1707. doi: 10.2967/jnumed.121.263511. Epub 2022 Apr 28. J Nucl Med. 2022. PMID: 35483965 Free PMC article.
Evaluating CD133 as a Radiotheranostic Target in Small-Cell Lung Cancer.
Sarrett SM, Rodriguez C, Delaney S, Hosny MM, Sebastiano J, Santos-Coquillat A, Keinänen OM, Carter LM, Lastwika KJ, Lampe PD, Zeglis BM. Sarrett SM, et al. Among authors: lastwika kj. Mol Pharm. 2024 Mar 4;21(3):1402-1413. doi: 10.1021/acs.molpharmaceut.3c01063. Epub 2024 Feb 8. Mol Pharm. 2024. PMID: 38331430 Free PMC article.
Ink4a/Arf loss promotes tumor recurrence following Ras inhibition.
Vanbrocklin MW, Robinson JP, Lastwika KJ, McKinney AJ, Gach HM, Holmen SL. Vanbrocklin MW, et al. Among authors: lastwika kj. Neuro Oncol. 2012 Jan;14(1):34-42. doi: 10.1093/neuonc/nor184. Epub 2011 Oct 20. Neuro Oncol. 2012. PMID: 22015595 Free PMC article.
14 results